T2 Biosystms Shares Outstanding vs. Price To Book
| TTOO Stock | USD 0.52 0.01 1.96% |
For T2 Biosystms profitability analysis, we use financial ratios and fundamental drivers that measure the ability of T2 Biosystms to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well T2 Biosystms utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between T2 Biosystms's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of T2 Biosystms over time as well as its relative position and ranking within its peers.
TTOO |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.03) | Revenue Per Share 0.999 | Quarterly Revenue Growth (0.01) | Return On Assets (0.90) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
T2 Biosystms Price To Book vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining T2 Biosystms's current stock value. Our valuation model uses many indicators to compare T2 Biosystms value to that of its competitors to determine the firm's financial worth. T2 Biosystms is rated below average in shares outstanding category among its peers. It is rated second in price to book category among its peers . The ratio of Shares Outstanding to Price To Book for T2 Biosystms is about 1,450,801 . As of the 11th of December 2024, Price To Book Ratio is likely to grow to -0.56. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the T2 Biosystms' earnings, one of the primary drivers of an investment's value.TTOO Price To Book vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
T2 Biosystms |
| = | 21.04 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
T2 Biosystms |
| = | 14.50 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
TTOO Price To Book Comparison
T2 Biosystms is currently under evaluation in price to book category among its peers.
T2 Biosystms Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in T2 Biosystms, profitability is also one of the essential criteria for including it into their portfolios because, without profit, T2 Biosystms will eventually generate negative long term returns. The profitability progress is the general direction of T2 Biosystms' change in net profit over the period of time. It can combine multiple indicators of T2 Biosystms, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -49.7 M | -52.1 M | |
| Income Before Tax | -50.1 M | -52.6 M | |
| Total Other Income Expense Net | -413 K | -433.6 K | |
| Net Loss | -50.1 M | -52.6 M | |
| Income Tax Expense | 691.1 K | 656.5 K | |
| Net Loss | -49.8 M | -52.3 M | |
| Non Operating Income Net Other | 97.8 K | 92.9 K | |
| Net Loss | -56.4 M | -59.2 M | |
| Interest Income | 7.2 K | 6.8 K | |
| Net Interest Income | -5.7 M | -6 M | |
| Change To Netincome | 11.5 M | 8.1 M | |
| Net Loss | (19.19) | (20.15) | |
| Income Quality | 0.96 | 0.94 | |
| Net Income Per E B T | 1.02 | 1.17 |
TTOO Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on T2 Biosystms. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of T2 Biosystms position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the T2 Biosystms' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in T2 Biosystms without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Use Investing Themes to Complement your T2 Biosystms position
In addition to having T2 Biosystms in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long/short ETFs Thematic Idea Now
Long/short ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Long/short ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long/short ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
To fully project T2 Biosystms' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of T2 Biosystms at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include T2 Biosystms' income statement, its balance sheet, and the statement of cash flows.